New and Emerging Trends in Cancer Treatment: CAR-T

In this Syndicated Report focusing on CAR-T therapy, and new and emerging trends in Cancer Treatment, we had two main objectives:

  • To understand the knowledge and excitement level for emerging trends in cancer treatment, specifically with chimeric antigen receptor T cell (CAR-T) therapy
  • To understand the drivers of use and future expectations for autologous vs. allogeneic CAR-T

Interview Exploration: n=3 30-minute interviews with Hematologists profiled as “thought leaders” in new cancer treatments to share experience and hypotheses prior to survey
3-Minute MicroSurvey
Crowds: US Hematologists, US Oncologists
Fielding Period: August 13-15, 2019

Download the report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more
ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more